These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1391073)

  • 1. [Insulin resistance and arterial hypertension].
    Ryder E
    Invest Clin; 1992; 33(1):1-3. PubMed ID: 1391073
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between parameters of hemostasis and manifestations of the metabolic syndrome in men with mild and moderate hypertension].
    Ratnikova LA; Metel'skaia VA; Mamedov MN; Olfer'ev AM; Perova NV
    Ter Arkh; 2000; 72(9):13-6. PubMed ID: 11076408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome' in a middle-aged Finnish population.
    Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Takala JK
    J Cardiovasc Risk; 1997 Aug; 4(4):291-5. PubMed ID: 9477208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndrome X: what's old, what's new, what's etiologic?
    Ginsberg HN
    J Clin Invest; 1993 Jul; 92(1):3. PubMed ID: 8325997
    [No Abstract]   [Full Text] [Related]  

  • 5. [Insulin resistance and metabolic syndrome in first-degree relatives of patients with NIDDM].
    Camps I; Biarnés J; Fernández-Real JM; Insa R; Soler J; Fernández Castañer M
    Med Clin (Barc); 1999 Mar; 112(8):281-4. PubMed ID: 10207842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R
    Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tissue insulin resistance and endothelial function of large vessels in patients with arterial hypertension].
    Baĭramgulov FM; Bulgakova AD; Kurelenkova ME; Kurbangaleeva LKh; Zakirova ZS; Timirkhanova FL; Bikmetova NR
    Ter Arkh; 2002; 74(12):24-6. PubMed ID: 12577834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations of insulin resistance and neoplasms].
    Suba Z; Ujpál M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension, insulin resistance, and the metabolic syndrome.
    Natali A; Ferrannini E
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperinsulinemia--the common denominator in type II diabetes mellitus,obesity, hypertension, hypertriglyceridemia and atherosclerosis].
    Málková J; Andĕl M; Stolba P; Kimlová I
    Cas Lek Cesk; 1994 Jan; 133(2):41-5. PubMed ID: 8131178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspects of hypertensive heart in arterial hypertension and insulin-resistant syndrome].
    Didenko VA; Simonov DV
    Klin Med (Mosk); 1999; 77(6):28-33. PubMed ID: 10459216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the metabolic syndrome and its influencing factors among adolescent girls in Mashhad, Iran.
    Mirhosseini NZ; Yusoff NA; Shahar S; Parizadeh SM; Mobarhen MG; Shakery MT
    Asia Pac J Clin Nutr; 2009; 18(1):131-6. PubMed ID: 19329406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, hyperinsulinemia and hypertension.
    Weidmann P; de Courten M; Böhlen L
    J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic syndrome with vascular risk and arterial hypertension].
    Wassermann AO; Grosso CP
    Medicina (B Aires); 1996; 56(2):183-94. PubMed ID: 8935572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives.
    Gudbjörnsdottir S; Elam M; Sellgren J; Anderson EA
    J Hypertens; 1996 Jan; 14(1):91-7. PubMed ID: 12013500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin resistance syndrome.
    Smolar EN
    Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.